报价延迟最少15分钟:2025/11/16 02:45 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.25 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.02/--
|
|
企业价值
713.68M
|
| 资产负债 |
|
每股账面净值
0.07
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/11/16 02:45 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering. |
